Provide medical input into the design of the clinical development program for drugs that are in Phase 1, 2, or 3 of development. Serve as a medical monitor for clinical studies (provide medical oversight of the study; answer questions about eligibility; review safety and adverse event information). Assist in the preparation of clinical protocols and FDA documents (INDs, annual reports, meeting requests, briefing books, and NDAs).